Michael Henry
About
Michael Henry is from Berkeley, California, United States. Michael is currently Chief Business Officer at Aldatu Biosciences, located in Greater Boston Area. Michael also works as Member at Berkeley Angel Network, a job Michael has held since Jan 2017. In Michael's previous role as a Senior Vice President and General Manager, Consumer Genomics at Centrillion Biosciences, Inc., Michael worked in San Francisco Bay Area until Jan 2018. Prior to joining Centrillion Biosciences, Inc., Michael was a Vice President, Business Development at Ancestry and held the position of Vice President, Business Development at San Francisco Bay Area. Prior to that, Michael was a Member at Launchpad Venture Group, based in Greater Boston Area from Jan 2014 to Jan 2015. Michael started working as Board of Directors at AboGen, Inc. in Portland, Maine Area in Jan 2014. From Jan 2013 to Jan 2014, Michael was Vice President, Business Development at Quest Diagnostics, Inc., based in Greater Boston Area. Prior to that, Michael was a Vice President, Business Development at Athena Diagnostics, Inc., based in Greater Boston Area from Jan 2004 to Jan 2013. Michael started working as Board of Directors at Cognoptix, Inc. in Greater Boston Area in Jan 2008.
Michael Henry can be found on Finalscout.com, where members can access Michael Henry's email for free. Finalscout is a professional database with more than 500 million business professional profiles and 200 million company profiles.
Michael Henry's current jobs
Michael Henry's past jobs
Reporting to the CEO, led strategy, marketing, operations, new product development, financing and deal making for the consumer genomics business at Centrillion. • Negotiated a TeloYears Advanced Ancestry DNA test agreement with Telomere Diagnostics.
Led business development for AncestryDNA and AncestryHealth, subsidiaries of Ancestry, a $683 million 2015 revenue consumer internet company and leader in online genealogy and consumer genomics. • Sold Ancestry to Silver Lake and GIC for $2.6 billion in 2016. • Led the team that managed the longevity therapeutics target discovery collaboration with Calico, an Alphabet / Google company. • Secured a genotyping test services collaboration agreement with Quest Diagnostics.
Led business development for the General Health and Wellness franchise, a $1.8 billion 2012 revenue segment of Quest Diagnostics, a $7.2 billion 2012 revenue diagnostics laboratory. • Acquired Summit Health, a provider of on-site wellness programs for employers, health plans and retail clinics, for $113 million plus a $25 million contingent payment.
Reporting to the CEO, led business development including mergers, acquisitions, divestitures, patents, licensing, strategic planning, launching new businesses and supervision of five staff for a $110 million 2010 revenue genetic testing laboratory. • Sold Athena to Quest Diagnostics for $740 million in 2011. • Sold Athena to Fisher Scientific for $283 million in 2006. • Licensed and/or launched 271 new products during 2004-2012 achieving double digit new product sales growth.